Forteo 560 MCG/2.24 ML pen INJ 2.24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FAKGC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,461
Award facts
- Contract value 100% obligated
- $10,460.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,460.85 to AmerisourceBergen Drug Corp for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections. The contract, a firm fixed-price delivery order with no set-aside designation, was awarded on December 29, 2025, with an ultimate completion date of December 30, 2025. Performance will occur at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order operates as a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The company's DLA IDC enables the supply of brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This specific delivery order for Forteo—a bone-density medication used in osteoporosis treatment—reflects the company's role in fulfilling targeted federal medical supply requirements within its existing contract framework.
Quick answers
Who was awarded contract SPE2DR26FAKGC?
SPE2DR26FAKGC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FAKGC worth?
The government has obligated $10,461 on SPE2DR26FAKGC.
Is contract SPE2DR26FAKGC an order under another contract?
Yes. SPE2DR26FAKGC is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKGC competed?
The extent of competition for SPE2DR26FAKGC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award